BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Takuji Tanaka, Mayu Tanaka, Takahiro Tanaka, Rikako Ishigamori. Biomarkers for Colorectal CancerInternational Journal of Molecular Sciences 2010; 11(9): 3209 doi: 10.3390/ijms11093209
2
Daniel Fatela-Cantillo, Antonio Fernandez-Suarez, Miguel Alonso Marin Moreno, Juan Jesus Puente Gutierrez, Jose Miguel Diaz Iglesias. Prognostic value of plasmatic tumor M2 pyruvate kinase and carcinoembryonic antigen in the survival of colorectal cancer patientsTumor Biology 2012; 33(3): 825 doi: 10.1007/s13277-011-0304-0
3
Haili Wu, Zongwei Li, Peng Yang, Lichao Zhang, Yongsheng Fan, Zhuoyu Li. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cellsCellular Signalling 2014; 26(11): 2397 doi: 10.1016/j.cellsig.2014.07.024
4
N. P. Voskresenskaya, E. N. Bylinsky. Notable and anniversary dates in biochemistry for 2005Biochemistry (Moscow) 2005; 70(1): 113 doi: 10.1007/s10541-005-0013-7
5
Sybille Mazurek, C. Bruce Boschek, Ferdinand Hugo, Erich Eigenbrodt. Pyruvate kinase type M2 and its role in tumor growth and spreadingSeminars in Cancer Biology 2005; 15(4): 300 doi: 10.1016/j.semcancer.2005.04.009
6
Adam Rzechonek, Aleksandra Kaminska, Piotr Mamczur, Arkadiusz Drapiewski, Władysław Budzynski. Pathobiology of Pulmonary DisordersAdvances in Experimental Medicine and Biology 2016; 955: 51 doi: 10.1007/5584_2016_92
7
Oh-Hyung Kwon, Tae-Wook Kang, Jeong-Hwan Kim, Mirang Kim, Seung-Moo Noh, Kyu-Sang Song, Hyang-Sook Yoo, Woo-Ho Kim, Zhi Xie, David Pocalyko, Seon-Young Kim, Yong Sung Kim. Pyruvate kinase M2 promotes the growth of gastric cancer cells via regulation of Bcl-xL expression at transcriptional levelBiochemical and Biophysical Research Communications 2012; 423(1): 38 doi: 10.1016/j.bbrc.2012.05.063
8
Sha Tao, Sabrina Hundt, Ulrike Haug, Hermann Brenner. Sensitivity Estimates of Blood-Based Tests for Colorectal Cancer Detection: Impact of Overrepresentation of Advanced Stage DiseaseAmerican Journal of Gastroenterology 2011; 106(2): 242 doi: 10.1038/ajg.2010.393
9
Ranju Ralhan, Leroi V. DeSouza, Ajay Matta, Satyendra Chandra Tripathi, Shaun Ghanny, Siddartha Datta Gupta, Sudhir Bahadur, K. W. Michael Siu. Discovery and Verification of Head-and-neck Cancer Biomarkers by Differential Protein Expression Analysis Using iTRAQ Labeling, Multidimensional Liquid Chromatography, and Tandem Mass SpectrometryMolecular & Cellular Proteomics 2008; 7(6): 1162 doi: 10.1074/mcp.M700500-MCP200
10
Xinyan Zhang, Fan Yang, Joong-Youn Shim, Kenneth L. Kirk, D. Eric Anderson, Xiaoxin Chen. Identification of arsenic-binding proteins in human breast cancer cellsCancer Letters 2007; 255(1): 95 doi: 10.1016/j.canlet.2007.03.025
11
Philip D Hardt, Nils Ewald. Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancyExpert Review of Molecular Diagnostics 2008; 8(5): 579 doi: 10.1586/14737159.8.5.579
12
Sanna A. Mulder, Monique E. van Leerdam, Anneke J. van Vuuren, Jan Francke, Albert W. van Toorenenbergen, Ernst J. Kuipers, Rob J. Th. Ouwendijk. Tumor pyruvate kinase isoenzyme type M2 and immunochemical fecal occult blood test: performance in screening for colorectal cancerEuropean Journal of Gastroenterology & Hepatology 2007; 19(10): 878 doi: 10.1097/MEG.0b013e3282cfa49c
13
Shao Thing Teoh, Sophia Y. Lunt. Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyondWiley Interdisciplinary Reviews: Systems Biology and Medicine 2018; 10(2): e1406 doi: 10.1002/wsbm.1406
14
Wen Meng, Hong-Hong Zhu, Ze-Feng Xu, Shan-Rong Cai, Qi Dong, Qiang-Rong Pan, Shu Zheng, Su-Zhan Zhang. Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screeningWorld Journal of Gastrointestinal Oncology 2012; 4(6): 145-151 doi: 10.4251/wjgo.v4.i6.145
15
Carolin Tonus, Gero Neupert, Markus Sellinger. Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PKWorld Journal of Gastroenterology 2006; 12(43): 7007-7011 doi: 10.3748/wjg.v12.i43.7007
16
Elżbieta Czub, Karl-Heinz Herzig, Anna Szaflarska-Popławska, Karlheinz Kiehne, Piotr Socha, Halina Woś, Barbara Kamińska, Michal Błaszczyński, Wojciech Cichy, Grażyna Bała, Jacek Brodzicki, Urszula Grzybowska-Chlebowczyk, Jarosław Walkowiak. Fecal pyruvate kinase: A potential new marker for intestinal inflammation in children with inflammatory bowel diseaseScandinavian Journal of Gastroenterology 2007; 42(10): 1147 doi: 10.1080/00365520701320513
17
Harsha R. Hathurusinghe, Kolitha S. Goonetilleke, Ajith K. Siriwardena. Current Status of Tumor M2 Pyruvate Kinase (Tumor M2-PK) as a Biomarker of Gastrointestinal MalignancyAnnals of Surgical Oncology 2007; 14(10): 2714 doi: 10.1245/s10434-007-9481-x
18
Thian-Sze Wong, Xiao-Bing Liu, Ambrose Chung-Wai Ho, Anthony Po-Wing Yuen, Raymond Wai-Man Ng, William Ignace Wei. Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profilingInternational Journal of Cancer 2008; 123(2): 251 doi: 10.1002/ijc.23583
19
Poh-Kuan Chong, Huiyin Lee, Marie Chiew Shia Loh, Lee-Yee Choong, Qingsong Lin, Jimmy Bok Yan So, Khong Hee Lim, Ross Andrew Soo, Wei Peng Yong, Siew Pang Chan, Duane T. Smoot, Hassan Ashktorab, Khay Guan Yeoh, Yoon Pin Lim. Upregulation of plasma C9 protein in gastric cancer patientsPROTEOMICS 2010; 10(18): 3210 doi: 10.1002/pmic.201000127
20
Ponnusamy Kalaiarasan, Naidu Subbarao, Rameshwar NK Bamezai. Molecular simulation of Tyr105 phosphorylated pyruvate kinase M2 to understand its structure and dynamicsJournal of Molecular Modeling 2014; 20(9) doi: 10.1007/s00894-014-2447-6
21
Juergen Ervens, Hendrik Fuchs, Volker-Till Niemann, Bodo Hoffmeister. Pyruvate kinase isoenzyme M2 is not of diagnostic relevance as a marker for oral cancerJournal of Cranio-Maxillofacial Surgery 2008; 36(2): 89 doi: 10.1016/j.jcms.2007.08.006
22
Yogesh Kumar, Niteen Tapuria, Naveed Kirmani, Brian R. Davidson. Tumour M2-pyruvate kinase: a gastrointestinal cancer markerEuropean Journal of Gastroenterology & Hepatology 2007; 19(3): 265 doi: 10.1097/MEG.0b013e3280102f78
23
Mark M Aloysius, Abed M Zaitoun, Timothy E Bates, Abdulkader Albasri, Mohammad Ilyas, Brian J Rowlands, Dileep N Lobo. Complete absence of M2-pyruvate kinase expression in benign pancreatic ductal epithelium and pancreaticobiliary and duodenal neoplasiaBMC Cancer 2009; 9(1) doi: 10.1186/1471-2407-9-327
24
S. S. Shishkin, L. I. Kovalyov, M. A. Kovalyova. Proteomic studies of human and other vertebrate muscle proteinsBiochemistry (Moscow) 2004; 69(11): 1283 doi: 10.1007/s10541-005-0074-7
25
Zongwei Li, Peng Yang, Zhuoyu Li. The multifaceted regulation and functions of PKM2 in tumor progressionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2014; 1846(2): 285 doi: 10.1016/j.bbcan.2014.07.008
26
Ponnusamy Kalaiarasan, Bhupender Kumar, Rupali Chopra, Vibhor Gupta, Naidu Subbarao, Rameshwar N. K. Bamezai, Rizwan H. Khan. In Silico Screening, Genotyping, Molecular Dynamics Simulation and Activity Studies of SNPs in Pyruvate Kinase M2PLOS ONE 2015; 10(3): e0120469 doi: 10.1371/journal.pone.0120469
27
Yogesh Kumar, Inigo R. Pinedo, Niteen Tapuria, Abigail Zabron, Brian R. Davidson. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastasesEuropean Journal of Gastroenterology & Hepatology 2008; 20(10): 1006 doi: 10.1097/MEG.0b013e3282f857a7
28
Mohd Askandar Iqbal, Vibhor Gupta, Prakasam Gopinath, Sybille Mazurek, Rameshwar N.K. Bamezai. Pyruvate kinase M2 and cancer: an updated assessmentFEBS Letters 2014; 588(16): 2685 doi: 10.1016/j.febslet.2014.04.011
29
Luca Meoli, Nitin K. Gupta, Nima Saeidi, Courtney A. Panciotti, Sudha B. Biddinger, Kathleen E. Corey, Nicholas Stylopoulos. Nonalcoholic fatty liver disease and gastric bypass surgery regulate serum and hepatic levels of pyruvate kinase isoenzyme M2American Journal of Physiology-Endocrinology and Metabolism 2018; 315(4): E613 doi: 10.1152/ajpendo.00296.2017
30
Gang Wang, Jun-Jie Wang, Rui Guan, Yan Sun, Feng Shi, Jing Gao, Xing-Li Fu. Targeting Strategies for Glucose Metabolic Pathways and T Cells in Colorectal CancerCurrent Cancer Drug Targets 2019; 19(7): 534 doi: 10.2174/1568009618666181015150138
31
S. Yeluri, B. Madhok, K. R. Prasad, P. Quirke, D. G. Jayne. Cancer’s craving for sugar: an opportunity for clinical exploitationJournal of Cancer Research and Clinical Oncology 2009; 135(7): 867 doi: 10.1007/s00432-009-0590-8
32
Béla Molnár, Kinga Tóth, Barbara Kinga Barták, Zsolt Tulassay. Plasma methylated septin 9: a colorectal cancer screening markerExpert Review of Molecular Diagnostics 2015; 15(2): 171 doi: 10.1586/14737159.2015.975212
33
Matt W. Johnson, Susan Maestranzi, Audrey M. Duffy, David H. Dewar, Paul J. Ciclitira, Roy A. Sherwood, John R. Nicholls. Faecal M2-pyruvate kinase: a novel, noninvasive marker of ileal pouch inflammationEuropean Journal of Gastroenterology & Hepatology 2009; 21(5): 544 doi: 10.1097/MEG.0b013e3283040cb3
34
Hua-shan Shi, Dan Li, Jing Zhang, Yong-sheng Wang, Li Yang, Hai-long Zhang, Xian-huo Wang, Bo Mu, Wei Wang, Yu Ma, Fu-chun Guo, Yu-quan Wei. Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in miceCancer Science 2010; 101(6): 1447 doi: 10.1111/j.1349-7006.2010.01562.x
35
Young-Kyoung Shin, Byong Chul Yoo, Yong Sang Hong, Hee Jin Chang, Kyung Hae Jung, Seung-Yong Jeong, Jae-Gahb Park. Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistanceELECTROPHORESIS 2009; 30(12): 2182 doi: 10.1002/elps.200800806